| 12281114 |
NK3 modulators and uses thereof |
Shuwen He, Scott B. JOSEPH, Tesfaye Biftu, Santhosh F. Neelamkavil |
2025-04-22 |
|
| 11512065 |
GPR119 agonists |
Iyassu Sebhat, Shuwen He |
2022-11-29 |
|
| 11041009 |
Glucose responsive insulin comprising a tri-valent sugar cluster for treatment of diabetes |
Danqing Feng, Pei Huo, Ahmet Kekec, Songnian Lin, Ravi Nargund +4 more |
2021-06-22 |
$110,392,000 |
| 9884125 |
Glucose-responsive insulin conjugates |
Songnian Lin |
2018-02-06 |
$115,479,000 |
| 9006228 |
Substituted cyclopropyl compounds, compositions containing such compounds, and methods of treatment |
Michael Miller, Andrew Stamford, Kallol Basu, Harold B. Wood, Duane DeMong +7 more |
2015-04-14 |
$69,458,000 |
| 8604038 |
Pyrrolidine derived beta 3 adrenergic receptor agonists |
Scott D. Edmondson, Lehua Chang, Nam Fung Kar, Gergori J. Morriello, Dong-Ming Shen +9 more |
2013-12-10 |
$69,974,000 |
| 8354403 |
Pyrrolidine derived beta 3 adrenergic receptor agonists |
Scott D. Edmondson, Richard Berger, Lehua Chang, Vincent J. Colandrea, Jeffrey J. Hale +9 more |
2013-01-15 |
$88,184,000 |
| 7786305 |
Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
Richard Jiao, Gregori J. Morriello, Lihu Yang, Changyou Zhou, Shankaran Kothandaraman |
2010-08-31 |
$54,653,000 |
| 7598243 |
Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity |
Gabor Butora, Stephen D. Goble, Alexander Pasternak, Lihu Yang, Changyou Zhou |
2009-10-06 |
$46,778,000 |
| 7442701 |
Amino-heterocycles as VR-1 antagonists for treating pain |
Peter Blurton, Frank Burkamp, Stephen Robert Fletcher, Gregory John Hollingworth, A. Brian Jones +2 more |
2008-10-28 |
$78,190,000 |
| 7285563 |
Heteroaromatic urea derivatives as VR-1 receptor modulators for treating pain |
Rebecca Brown, Victoria Alexandra Doughty, Gregory John Hollingworth, A. Brian Jones, Matthew Lindon +1 more |
2007-10-23 |
|
| 7230008 |
Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
Richard Jiao, Gabor Butora, Stephen D. Goble, Deodialsingh Guiadeen, Sander G. Mills +6 more |
2007-06-12 |
$470,275,000 |
| 7166614 |
Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
Richard Jiao, Stephen D. Goble, Sander G. Mills, Gregori J. Morriello, Alexander Pasternak +5 more |
2007-01-23 |
$86,171,000 |
| 6812234 |
Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
Richard Jiao, Gregori J. Morriello, Lihu Yang, Stephen D. Goble, Sander G. Mills +6 more |
2004-11-02 |
$92,696,000 |
| 6608062 |
Imidazo-triazine derivatives as ligands for GABA receptors |
William R. Carling, Alexander Richard Guiblin, Kevin W. Moore, Michael Rowley, Leslie Joseph Street |
2003-08-19 |
$586,986,000 |
| 6479480 |
Phenylindole derivatives as 5-ht2a receptor ligands |
Michael Rowley |
2002-11-12 |
$64,394,000 |
| 6352994 |
Substituted 1H-pyridinyl-2-ones as GABAA alpha 2/3 ligands |
Ian Collins, Stephen Robert Fletcher, Timothy Harrison, Paul D. Leeson, Alan John Nadin +3 more |
2002-03-05 |
$181,352,000 |
| 6200982 |
Substituted 1H-pyridinyl-2-ones as GABAA-.alpha. 2/3 ligands |
Ian Collins, Stephen Robert Fletcher, Timothy Harrison, Paul D. Leeson, Alan John Nadin +3 more |
2001-03-13 |
$219,477,000 |
| 6133255 |
Tricyclic pyridone analogues as GABA-A receptor ligands |
Timothy Harrison, Richard T. Lewis, Alan John Nadin, Andrew Pate Owens |
2000-10-17 |
$293,277,000 |
| 6048878 |
Substituted piperidine derivatives as selective agonists of 5-HT receptors |
Jose Luis Castro Pineiro, Ian Collins, Angus Murray MacLeod, Michael Rowley, Graham Andrew Showell |
2000-04-11 |
$235,063,000 |
